Lv6
1940 积分 2023-08-21 加入
Precision therapeutics and emerging strategies for HR-positive metastatic breast cancer
1天前
已完结
PI3K Inhibitors in Breast Cancer Therapy
1天前
已完结
Inavolisib: a second-generation PI3Kα inhibitor in HR+/HER2-negative breast cancer
2天前
待确认
Overall Survival with Inavolisib in PIK3CA -Mutated Advanced Breast Cancer
2天前
已完结
Development of novel urea-based ATM kinase inhibitors with subnanomolar cellular potency and high kinome selectivity
4天前
已完结
Identification of Novel, Selective Ataxia-Telangiectasia Mutated Kinase Inhibitors with the Ability to Penetrate the Blood–Brain Barrier: The Discovery of AZD1390
4天前
已完结
Omipalisib inspired macrocycles as dual PI3K/mTOR inhibitors
5天前
已完结
Alicyclic‐Amine‐Derived Imine‐BF3 Complexes: Easy‐to‐Make Building Blocks for the Synthesis of Valuable α‐Functionalized Azacycles
6天前
已完结
Opportunities and challenges in the development of evolving EGFR inhibitors to overcome EGFR TKIs resistance
6天前
已完结
Synthesis and Evaluation of Novel Aza-Aromatics as Dual 5‑HT2A and 5‑HT2C Receptor Agonists
7天前
已完结
皖公网安备34019202002308
